Academe Learn
CBME Curriculum Preview

Page 33 of 33

PE12.1-8,PE13.1-4 | Micronutrients — PBL Case

CLINICAL SETTING

A rural sub-district hospital in a hilly area of Jharkhand. It serves 12 villages with predominantly tribal population. The nearest city is 4 hours away. A mother has brought her 18-month-old son, Ratan, complaining that 'he was walking a few weeks ago but now refuses to stand.' She adds that he cries when she tries to lift him. The local ASHA worker accompanies them and mentions that two other toddlers in the same village have similar problems. It is November — a month with minimal sunlight exposure.

Trigger 1: Initial Presentation

Ratan, 18 months old. Weight: 7.0 kg (<-3 SD on WHO charts). Length: 72 cm (<-3 SD). He is irritable and pale. On examination, you note: generalised hypotonia; extreme tenderness on palpation of both femurs and lower limbs (he screams); adopts a 'frog-leg' posture; marked bowing of the lower limbs; swollen wrists with 'rachitic rosary' of the ribs. The mother says he has been fed exclusively on maize porridge, some lentils, no dairy, no eggs, and no fruits since 6 months. He did not receive any injections at birth (home delivery). No supplementation has ever been given.

DISCUSSION POINTS

  • What is your differential diagnosis for a toddler who refuses to walk with limb tenderness and bowing of legs? What are the most urgent conditions to exclude?
  • From the dietary history and physical examination, which micronutrient deficiencies are you already suspecting and why? What clinical signs correspond to each suspected deficiency?
  • Why is the 'frog-leg posture' a high-yield sign? What does extreme limb tenderness in an 18-month-old suggest?
  • The ASHA worker mentions two more children with similar symptoms. What does this community clustering imply and how does it change your approach?
Click to reveal Trigger 2: Examination Findings and First Results (discuss previous trigger first!)

Trigger 2: Examination Findings and First Results

Further examination reveals: pale conjunctivae; triangular foamy whitish patches bilaterally on the temporal bulbar conjunctiva; bleeding from the gingival margin when gently touched; scattered dark purpuric spots in a perifollicular distribution on both thighs. Wrist X-ray: marked cupping and fraying of distal radial and ulnar metaphyses; a dense white line at the metaphysis with a radiolucent band just below it, and corner fractures of the lateral metaphyseal margins. Blood results: Hb 7.5 g/dL, MCV 60 fL, serum ferritin 5 ng/mL, CRP normal. Serum calcium 7.2 mg/dL, phosphate 2.8 mg/dL, alkaline phosphatase 890 IU/L. Serum 25-OH Vitamin D: 7 ng/mL (severely deficient). PTH: 380 pg/mL.

DISCUSSION POINTS

  • Interpret the X-ray findings. Which radiological signs of rickets are described? What are the additional X-ray signs that together confirm scurvy? Can both conditions coexist in the same child?
  • The foamy triangular patches on the conjunctiva are what sign? At what xerophthalmia classification stage is this? What immediate therapeutic action is required?
  • The elevated PTH with low calcium and low Vitamin D confirms which mechanism? How does Vitamin D deficiency lead to secondary hyperparathyroidism and why is this relevant to management?
  • The low MCV, low ferritin, and normal CRP confirm what? How does the dietary history explain the co-occurrence of iron deficiency alongside Vitamin C and Vitamin D deficiencies?
Click to reveal Trigger 3: Management Decisions — The Therapeutic Cascade (discuss previous trigger first!)

Trigger 3: Management Decisions — The Therapeutic Cascade

The consultant paediatrician has confirmed: rickets (Vitamin D deficiency), scurvy (Vitamin C deficiency), xerophthalmia stage X1B (Vitamin A deficiency), and iron deficiency anaemia. She is drafting the management plan. She asks you to calculate the stoss dose for Vitamin D, look up the xerophthalmia therapeutic schedule, calculate the therapeutic iron dose for Ratan (7 kg), and plan the calcium co-supplementation. The nurse asks: 'Ratan was not given Vitamin K at birth — should we be worried about spontaneous bleeding?'

DISCUSSION POINTS

  • Calculate the Vitamin D stoss dose for Ratan. What is the route, what is the next dose, and what radiological sign will you look for at 4–6 weeks to confirm healing?
  • State the full xerophthalmia therapeutic schedule for a child of Ratan's age. What additional eye care is required? What is the prognosis for Bitot's spots with treatment?
  • Calculate the therapeutic oral iron dose for Ratan (7 kg). How long will you treat him? What response do you expect on CBC at 4 weeks?
  • Should you be worried about VKDB given no birth Vitamin K? At 18 months, classic VKDB (days 2–7) has passed. Is late VKDB (2–8 weeks) still a risk? What factors increase risk of late VKDB beyond the neonatal period?
  • Why must calcium be given alongside Vitamin D? What dose of calcium will you prescribe for Ratan?
Click to reveal Trigger 4: Community Prevention — Closing the Gap (discuss previous trigger first!)

Trigger 4: Community Prevention — Closing the Gap

Ratan is treated and improving. The District Health Officer visits and asks you to present recommendations for the village. The ASHA worker provides additional data: survey shows 18% of children aged 1–5 years have goitre (palpable). Salt testing from three homes shows iodine at 7, 9, and 12 ppm — all below 15 ppm. A review of immunisation records shows Vitamin A was not given at 9 months to 60% of children in the village. Haemoglobin survey shows 72% of children 6–59 months have Hb <11 g/dL.

DISCUSSION POINTS

  • The survey shows 18% TGR (Total Goitre Rate) in under-5 children. How would WHO/UNICEF classify the IDD burden in this community? What is the minimum iodine concentration in salt at consumer level under India's USI programme? What does the survey salt data tell you?
  • What Vitamin A prophylaxis failure is evident from the immunisation records? State the correct NIS schedule for Vitamin A in children 9 months to 5 years. What 'pulse' strategy is used to reach the community outside the NIS?
  • With 72% of children under-5 having anaemia, what NIPI schedule should be in place? What is the specific dose of elemental iron + folic acid for Ratan's age group (6–59 months)?
  • Draft a one-paragraph 'Five-Point Micronutrient Action Plan' for the District Health Officer addressing Vitamin A, Vitamin D, iron/IDA, iodine/IDD, and Vitamin C/scurvy prevention.

Group Task Assignments

Group 1: Collaborative Task

Group 2: Collaborative Task

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [PE12.1] What is the RDA for Vitamin A in children 1–3 years? What dietary sources are available in a tribal diet? How does Vitamin A metabolism differ in malnutrition (what limits retinol mobilisation from liver stores)?
  2. [PE12.2] What are the WHO xerophthalmia stages (XN, X1A, X1B, X2, X3A, X3B, XS)? What are the therapeutic and prophylactic doses per age group? How do Bitot's spots differ from XN and X2?
  3. [PE12.3] What are the causes and pathophysiology of nutritional rickets? What is the stoss dose and daily dose for treatment? What does the X-ray show in active rickets and in healing rickets (zone of provisional calcification)?
  4. [PE12.5] What is the RDA for Vitamin K? What foods are rich in Vitamin K? What is the role of Vitamin K in coagulation (which factors — II, VII, IX, X)?
  5. [PE12.6] What are the three types of VKDB (early, classic, late) with timing, causes, and clinical features? What is the prophylactic regimen — dose for term vs <1.5 kg neonates? What is the treatment of active VKDB?
  6. [PE12.7] What are the clinical features of thiamine, riboflavin, niacin (pellagra), pyridoxine, B12, and folate deficiencies? Which are most clinically relevant in Indian children? What is the unique risk of B12 deficiency in breastfed infants of vegan mothers?
  7. [PE12.8] What is the RDA for Vitamin C? What dietary sources are available in resource-limited settings? What are the classic radiological signs of scurvy? What is the treatment dose and duration?
  8. [PE13.1] What are the RDA, dietary sources, and absorption-enhancing/inhibiting factors for iron? What is the clinical presentation of IDA in a toddler? What is the therapeutic dose of elemental iron and the NIPI prophylactic dose?
  9. [PE13.2] What are the NIPI age-group schedules (6–59 months, 5–10 years, 10–19 years) including elemental iron dose, folic acid dose, and frequency? How does WIFS differ from NIPI in the adolescent age group?
  10. [PE13.3] What is the RDA for iodine? What are the IDD spectrum disorders? How is severity classified by TGR? What is the minimum iodine in salt under USI at production and consumer level? What is the newborn TSH screening threshold for congenital hypothyroidism?
  11. [PE13.4] What is the RDA for calcium and magnesium in children 1–3 years? Why is calcium deficiency a distinct cause of rickets (calcium-deficiency rickets) separate from Vitamin D deficiency? What is the calcium dose for co-supplementation in nutritional rickets?